DexCom: Revenue Up, EPS Misses Mark
Looking forward, DexCom's management has reiterated its fiscal year 2025 forecast, anticipating revenue growth of 14% with a ...
Analyst Cautiously Optimistic On DexCom As Competitive Pressures Loom
DexCom reported Q4 revenue of $1.11 billion, surpassing estimates. The company reaffirmed its 2025 outlook while analysts ...
Investor's Business Daily on MSN1h
Dexcom Stock Makes A Recovery After Its Fourth-Quarter Fumble
Dexcom stock stock recovered Friday after the diabetes devices maker missed fourth-quarter profit expectations.
Hosted on MSN9h
DexCom Stock Outlook: Is Wall Street Bullish or Bearish?
San Diego, California-based DexCom, Inc. (DXCM) is a medical device company that focuses on the design, development, and ...
Healio6h
Automated insulin delivery lowers HbA1c, improves time in range in type 2 diabetes
Adults with insulin-treated type 2 diabetes had a significant HbA1c decline at 13 weeks with use of the Omnipod 5 automated ...
DexCom Inc. stock outperforms competitors on strong trading day
Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch Automation brings you the latest, most pertinent content at record speed and with ...
Dexcom (DXCM) Gets a Buy from Stifel Nicolaus
Stifel Nicolaus analyst Mathew Blackman reiterated a Buy rating on Dexcom (DXCM – Research Report) today and set a price target of $100.00. The ...
RBC Capital Keeps Their Buy Rating on Dexcom (DXCM)
In a report released yesterday, Shagun Singh Chadha from RBC Capital reiterated a Buy rating on Dexcom (DXCM – Research Report), with a price ...